Prostate Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Men between 18 and 75 years of age
• People who have had a prostate biopsy within the last 6 months that confirmed prostate cancer that has not spread beyond the prostate, with a cancer stage of T1c to T2b, N0M0
• People whose cancer has a Gleason Score (a measure of cancer aggressiveness) below 8
• People whose PSA level (a blood marker for prostate cancer) is below 20 ng/ml
• People whose biopsy results show a specific type of prostate cancer called follicular adenocarcinoma or ductal adenocarcinoma
• People who had normal sexual function before surgery and wish to remain sexually active after surgery
• People whose general health makes them suitable for keyhole (laparoscopic) surgery
• People who are willing to attend all follow-up appointments and complete related tests throughout the study
• People who have agreed to take part and have signed a written consent form (either themselves or through an authorised representative)
• People who are able to complete study questionnaires written in Chinese

Who may not be able to join:

• People whose cancer is high-risk or has spread beyond the prostate (stage T2c or higher, Gleason Score of 8 or above, or PSA above 20 ng/ml)
• People with a special or rare type of prostate cancer, such as neuroendocrine cancer
• People who have had previous abdominal surgery or radiation therapy that could affect the surgical approach used in this trial
• People who have recently had surgery on the rectum, an abscess near the anus, a fistula in that area, or surgery in the perineal region
• People who have previously had a procedure to remove or reduce the prostate using electrical instruments
• People who have been treated for prostate cancer and have had less than 12 months of follow-up since that treatment (confirm with trial site)
• People with an ECOG performance score above 1, meaning those whose daily functioning is significantly limited by their health (confirm with trial site)
• People who have another cancer elsewhere in the body at the same time
• People who have already received any treatment aimed at fighting the cancer before this trial
• People with serious existing health conditions, including severe mental health disorders, heart or blood vessel disease, active infections, a bone marrow transplant within the past 3 months, or significantly poor organ function
• People who are currently taking part in another clinical trial or who have received any gene therapy in the past 3 months
• People who, in the researchers' judgement, have other circumstances that could affect the trial results or raise ethical concerns

Important: Always verify eligibility with the trial site directly before applying.